IFNG and cancer: A prime example is E. coli Nissle 1917, engineered with a quorum‐sensing circuit for the spatiotemporal release of IFN‐γ.[30] Collectively, these features provide engineered bacteria with unique and powerful advantages for maintaining high local drug concentrations and enabling long‐term immune activation against cancer.